GL1X · GenesisL1 explorer

Research workbench

Crystal structure of a novel dimeric form of HCV NS5A domain I protein

Analyse Crystal structure of a novel dimeric form of HCV NS5A domain I protein in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FQQ
Type
protein
Length
319 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-structural protein 5A
UniProt
Q9WMX2
Ligands
0BD, ZN
Pockets
2 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 5% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANon-structural protein 5Aprotein1605% helix, 41% strandQ9WMX2
BNon-structural protein 5Aprotein1595% helix, 37% strandQ9WMX2

Ligands and binding sites

  • 0BD · 3-methyl-1-(2-methylpropyl)butyl 4-O-beta-L-gulopyranosyl-beta-D-glucopyranoside · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15600.810.8659GOL
2560.270.7411empty

Interfaces

1 interface between chains.

  • A–B · 935 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 3FQQ · Crystal structure of a novel dimeric form of HCV NS5A domain I protein · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.